US Bancorp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,875
| Closed | -$905K | – | 4093 |
|
|
2023
Q2 | $905K | Sell |
8,875
-771
| -8% | -$78.6K | ﹤0.01% | 1103 |
|
|
2023
Q1 | $877K | Buy |
9,646
+8,947
| +1,280% | +$813K | ﹤0.01% | 1139 |
|
|
2022
Q4 | $26.6K | Buy |
699
+152
| +28% | +$5.77K | ﹤0.01% | 2837 |
|
|
2022
Q3 | $14K | Sell |
547
-792
| -59% | -$20.3K | ﹤0.01% | 3230 |
|
|
2022
Q2 | $41K | Sell |
1,339
-485
| -27% | -$14.9K | ﹤0.01% | 2682 |
|
|
2022
Q1 | $60K | Buy |
1,824
+1,647
| +931% | +$54.2K | ﹤0.01% | 2523 |
|
|
2021
Q4 | $5K | Buy |
177
+83
| +88% | +$2.35K | ﹤0.01% | 3652 |
|
|
2021
Q3 | $9K | Sell |
94
-533
| -85% | -$51K | ﹤0.01% | 3474 |
|
|
2021
Q2 | $89K | Sell |
627
-181
| -22% | -$25.7K | ﹤0.01% | 2380 |
|
|
2021
Q1 | $81K | Sell |
808
-220
| -21% | -$22.1K | ﹤0.01% | 2374 |
|
|
2020
Q4 | $127K | Buy |
1,028
+300
| +41% | +$37.1K | ﹤0.01% | 2090 |
|
|
2020
Q3 | $71K | Buy |
728
+49
| +7% | +$4.78K | ﹤0.01% | 2231 |
|
|
2020
Q2 | $105K | Sell |
679
-26
| -4% | -$4.02K | ﹤0.01% | 2064 |
|
|
2020
Q1 | $101K | Buy |
705
+460
| +188% | +$65.9K | ﹤0.01% | 1983 |
|
|
2019
Q4 | $50K | Buy |
245
+230
| +1,533% | +$46.9K | ﹤0.01% | 2476 |
|
|
2019
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 3534 |
|